Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GOlr Resource Report Resource Website 1+ mentions |
GOlr (RRID:SCR_003939) | GOlr | software resource | A public Solr index for the Gene Ontology. This index will replace some of the query functionality for GOOSE as well as become the new backend for AmiGO 2 and other services. | solr |
is used by: AmiGO has parent organization: Gene Ontology |
Public | nlx_158322 | http://golr.berkeleybop.org/ | SCR_003939 | Gene Ontology Solr index | 2026-07-25 12:05:44 | 4 | ||||||
|
American Society of Transplantation Resource Report Resource Website 1+ mentions |
American Society of Transplantation (RRID:SCR_003970) | AST | professional organization | An organization of transplant professionals dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation. | transplantation, patient care, organ donation, organ, training resource | is related to: Kidney Health Initiative | nlx_158377, Wikidata: Q4745115, Crossref funder ID: 100005160, ISNI: 0000 0001 0409 3433, grid.461608.d | https://ror.org/05cqqj259 | SCR_003970 | 2026-07-25 12:05:44 | 4 | ||||||||
|
Arbor Research Collaborative for Health Resource Report Resource Website 1+ mentions |
Arbor Research Collaborative for Health (RRID:SCR_003972) | Arbor Research | nonprofit organization | A not-for-profit research organization committed to improve patient care through research that shapes medical policies and practice. In particular, they conduct health outcomes research on chronic disease and end-stage organ failure, with expertise in biostatistical analysis, clinical practice, health economics, public policy, database management and integration, and project coordination. Through research projects that are national and global in scope, their scientific collaborations provide valuable and timely information to the worldwide health care community. They are a leader in interdisciplinary health outcomes and policy research focused on reducing the health and economic burden of chronic diseases and improving the delivery of care. | health outcome, patient care, clinical, policy, nephrology, statistics, kidney, transplant, dialysis, epidemiology, public health, clinical practice, policy development, medical payment system | is related to: Kidney Health Initiative | Kidney disease, Organ failure, Chronic disease | grid.413857.c, nlx_158379, ISNI: 0000 0004 0628 9837 | https://ror.org/043qmbk61 | SCR_003972 | URREA, University Renal Research and Education Association | 2026-07-25 12:05:46 | 3 | ||||||
|
American Nephrology Nurses Association Resource Report Resource Website 1+ mentions |
American Nephrology Nurses Association (RRID:SCR_003966) | ANNA | institution | Non-profit professional association that represents nurses who work in all areas of nephrology including hemodialysis, chronic kidney disease, peritoneal dialysis, acute care, and transplantation. Most members work in freestanding dialysis units, hospital outpatient units, and hospital inpatient units. ANNA develops and updates standards of clinical practice, educates practitioners, stimulates and supports research, disseminates knowledge and new ideas, promotes interdisciplinary communication and cooperation, and monitors and addresses issues encompassing the breadth of practice of nephrology nursing. | clinical, kidney, nephrology, nurse, health care, dialysis, journal, training resource |
is related to: Nephrology Nursing Certification Commission is related to: Kidney Health Initiative |
Kidney disease | grid.469735.a, nlx_158371, ISNI: 0000 0000 9310 7210, Crossref funder ID: 100005526 | https://ror.org/05a8c4g41 | SCR_003966 | American Nephrology Nurses'' Association | 2026-07-25 12:05:46 | 1 | ||||||
|
SOLVO Biotechnology Resource Report Resource Website 1+ mentions |
SOLVO Biotechnology (RRID:SCR_003964) | SOLVO | commercial organization | Commercial organization that is a worldwide provider of drug transporter technology, assays and reagents. Leveraging their expertise in efflux and uptake transporters, they generate quality reports for submission to FDA / EMA. From small molecules to protein therapeutics, SOLVO can test all transporter needs. Drug transporter Services and Products include: * Over 100 solutions for a wide range of transporters * Uptake transporter assays * Efflux transporter assays in cellular and membrane-based models * Transporter Consultancy Services * FDA- and EMA-ready reports * Ready-to-use Kits * In vitro and in vivo methods for studying transporters in the BBB, intestine, liver and kidney * Custom assay development | assay, membrane transporter, diagnostic, drug discovery, transporter, membrane | is related to: MIP-DILI | nlx_158367 | SCR_003964 | Solvo Biotechnology ZRT | 2026-07-25 12:05:44 | 2 | ||||||||
|
SeqExpress Resource Report Resource Website |
SeqExpress (RRID:SCR_004013) | software resource | A cross-platform software that estimates gene/isoform expression level via mRNA-Seq data. SeqExpress exams the Sequencing bias in mRNA-Seq and correct it to get more accurate estimation. | c++, mrna-seq, qt |
is listed by: OMICtools has parent organization: SourceForge |
PMID:15746290 PMID:14988116 |
GNU General Public License v2 | OMICS_01289 | SCR_004013 | 2026-07-25 12:05:47 | 0 | ||||||||
|
W. Garfield Weston Foundation Resource Report Resource Website |
W. Garfield Weston Foundation (RRID:SCR_004017) | Weston Foundation | institution | Foundation that gives grants in Canada for the benefit of Canadians and directs its resources to specific organizations in Education, Land Conservation and Science in Canada''s North. In addition, it provides funds to further Canada''s research in neuroscience. These programs are director-initiated and the Foundation therefore does not accept applications for funding. By law, the Foundation is only able to support Canadian charities that are registered with the Canadian Revenue Agency. These charities must have a CRA charitable number and offer programs benefiting Canadians in Canada. | education, land conservation, science, neuroscience, grant | is parent organization of: Weston Brain Institute | nlx_158436, grid.430570.5, Crossref funder ID: 501100000243 | https://ror.org/0512g3q82 | SCR_004017 | The W. Garfield Weston Foundation | 2026-07-25 12:05:47 | 0 | |||||||
|
CXR Biosciences Resource Report Resource Website |
CXR Biosciences (RRID:SCR_003961) | commercial organization | Commercial organization that provides preclinical services and expertise, specializing in investigative toxicology, exploratory and discovery toxicology, metabolism and pharmacokinetics. CXR Biosciences is now Concept Life Sciences. | preclinical, toxicology, metabolism, pharmacokinetics, in vitro, in vivo, analytic, genomics, microarray, toxicogenomics, compound, drug | is related to: MIP-DILI | nlx_158363 | https://www.linkedin.com/company/cxr-biosciences-ltd | SCR_003961 | Concept Life Sciences, CXR Biosciences Ltd. | 2026-07-25 12:05:44 | 0 | ||||||||
|
GABO:mi Resource Report Resource Website |
GABO:mi (RRID:SCR_003956) | GABO:mi | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021. Small and medium-sized enterprise (SME) that is expert in management of research projects. Initially, they provide support with help and advice when applying for European research grants - free of charge. From project start, they take over contract negotiations, financial management, reporting to the EC, meeting organization, public relations and much more. ARTTIC Innovation GmbH took over GAVBO:mi. | project management |
is related to: OncoTrack is related to: European Lead Factory is related to: EU-AIMS is related to: NEWMEDS is related to: ARTTIC Innovation GmbH |
grid.10404.31, nlx_158356, ISNI: 0000 0004 0377 0748 | https://ror.org/00a99v816 | SCR_003956 | GABO:mi Gesellschaft f??r Ablauforganisation :milliarium mbH & Co. KG, GABO MI Society for workflow management, GABO:mi Gesellschaft fur Ablauforganisation:milliarium mbH & Co. KG, GABO:mi Gesellschaft f??r Ablauforganisation:milliarium mbH & Co KG, GABO:mi Society for workflow management, GABO:mi Gesellschaft f??r Ablauforganisation:milliarium mbH & Co. KG, GABO:milliarium, GABO:mi Gesellschaft fur Ablauforganisation :milliarium mbH & Co. KG | 2026-07-25 12:05:45 | 0 | |||||||
|
Interface Europe Resource Report Resource Website |
Interface Europe (RRID:SCR_003955) | IE | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021.Commercial organization with expertise in European research and innovation that provide both science providers (researchers) and technology users (Industry including SMEs, public authorities, Universities, clusters, etc.) tailor-made services to give the highest possible European added value to their project. | European research and innovation |
is related to: MIP-DILI is parent organization of: MIP-DILI |
nlx_158364 | SCR_003955 | 2026-07-25 12:05:44 | 0 | |||||||||
|
Experimental Pharmacology and Oncology Berlin-Buch Resource Report Resource Website 1+ mentions |
Experimental Pharmacology and Oncology Berlin-Buch (RRID:SCR_003954) | EPO | commercial organization | A small and medium-sized enterprise (SME) that has expertise in preclinical pharmacology, pharmacokinetics, and toxicology for the characterization of novel anticancer therapeutics and predictive biomarkers like: cytostatics, biologicals (peptides, antibodies), (anti)-hormones, immunomodulators (cytokines), and gene therapeutics. EPO has modern laboratories licensed for animal experiments and gene technology (S2) and a broad panel of murine and human tumor models growing in immunocompetent (SPF-quality, syngeneic strains) or immunodeficient mice (nude, SCID, NOD/SCID). EPO has established imaging technologies to monitor in vivo tumor growth. | tumor model, pharmaceutical, oncology, in vitro, in vivo, antitumor, preclinical, pharmacology, pharmacokinetics, toxicology, anticancer, therapeutic, biomarker, imaging, testing, validation, target | is related to: OncoTrack | Tumor, Cancer | nlx_158355 | SCR_003954 | EPO - Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology Berlin-Buch, Experimental Pharmacology & Oncology Berlin-Buch GmbH, EPO Berlin-Buch GmbH, EPO-GmbH | 2026-07-25 12:05:46 | 2 | |||||||
|
Alacris Theranostics Resource Report Resource Website |
Alacris Theranostics (RRID:SCR_003953) | Alacris | commercial organization | Commercial organization that uses next generation sequencing technologies coupled with computational modeling of tumor and somatic tissues in order to identify individualized therapies for cancer patients. The company also uses these technologies to help pharmaceutical partners stratify patients for their clinical trials. Alacris has an exclusive worldwide commercial license for the computational modeling of tumors and somatic tissues using proprietary computational systems modeling technologies ModCell developed at the Max Planck Institute for Molecular Genetics (MPI-MG) in Berlin coupled with next generation sequencing and genotyping technology developed at Harvard Medical School in Boston. The company also is building up the first next generation sequencing center in Europe for clinical operations. | next generation sequencing, computational modeling, clinical trial, somatic tissue, genotyping, genomics, oncogenomics, diagnostics, therapy, disease model, drug, personalized medicine, biomarker, drug development, tumor model, analysis, oncology | is related to: OncoTrack | Tumor, Cancer | nlx_158354, grid.473915.d | https://ror.org/04a0gnr15 | SCR_003953 | Alacris Theranostics GmbH | 2026-07-25 12:05:45 | 0 | ||||||
|
Psynova Neurotech Resource Report Resource Website 1+ mentions |
Psynova Neurotech (RRID:SCR_003959) | Psynova | commercial organization | Commercial organization focused on the development and exploitation of novel biomarkers for psychiatric illnesses. They provide industrial and academic partners with comprehensive biomarker discovery services in commercial and collaborative projects. They operate in the field of psychiatric disorders and their products and services are designed to excel biomarker research. In 2010, Psynova Neurotech and its partner company Rules-Based-Medicine Inc (now MyriadRBM) conducted a beta launch of a blood test aiding in the diagnosis of schizophrenia (http://www.veripsych.com/). They are now refining the test and have shifted their focus to the development of new blood-based biomarker tests that aid in the diagnosis, prognosis and differential diagnosis of schizophrenia, bipolar disorder and major depression. They offer not only their pre-selceted Multiple Reaction Monitoring (MRM) and Multiplex Immunoassay products, but also custom build panels. If they are provided with a list of analyses to evaluate, they can produce an analytical panel according to individual needs utilizing either MRM or Multiplex Immunoassay technologies., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biomarker, neuropsychiatry, preclinical, model, diagnosis, blood, drug response, immunoassay, brain tissue, mass spectrometry, analysis |
is related to: University of Cambridge; Cambridge; United Kingdom is related to: NEWMEDS |
Schizophrenia, Psychiatric disorder, Bipolar Disorder, Major Depressive Disorder | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158360 | SCR_003959 | Psynova Neurotech Ltd | 2026-07-25 12:05:45 | 9 | ||||||
|
Coordinating center for infectious diseases Resource Report Resource Website |
Coordinating center for infectious diseases (RRID:SCR_003958) | CCID, CH | government granting agency | http://www.thecommunityguide.org/uses/funding.html | has parent organization: Centers for Disease Control and Prevention | nlx_inv_1005039 | SCR_003958 | 2026-07-25 12:05:44 | 0 | ||||||||||
|
Relypsa Resource Report Resource Website |
Relypsa (RRID:SCR_004047) | RLYP | commercial organization | Biopharmaceutical company focused on development and commercialization of non-absorbed polymeric drugs to treat disorders in areas of renal, cardiovascular and metabolic diseases.February 2021 - Relypsa changed its name to Vifor Pharma. Company is focused on development and commercialization of late stage medicines that will change treatment paradigms and improve patients lives. | biopharmaceutical, pharmaceutical, drug, late stage medicines, late stage medicines commercialization, late stage medicines development | is related to: Kidney Health Initiative | nlx_158475 | SCR_004047 | Relypsa Inc., Vifor Pharma | 2026-07-25 12:05:46 | 0 | ||||||||
|
CADRO Resource Report Resource Website 1+ mentions |
CADRO (RRID:SCR_004046) | CADRO | controlled vocabulary, data or information resource | A classification system developed by the National Institute on Aging and the Alzheimer's Association that can be used to integrate and compare Alzheimer's disease (AD) research portfolios from public and private organizations supporting AD research in the US and abroad. The CADRO was constructed as a three-tier classification system organized around seven major categories: five in research and two resource-related: * Category A. Molecular Pathogenesis and Pathophysiology of Alzheimer's Disease * Category B. Diagnosis, Assessment and Disease Monitoring * Category C. Translational Research and Clinical Interventions * Category D. Epidemiology * Category E. Care, Support and Health Economics of Alzheimer's Diseases * Category F. Research Resources * Category G. Consortia and Public Private Partnerships * Category H. Alzheimer's Disease - Related Dementias Using information from project abstracts and research aims, the above categories were stratified into research topics and these were further divided into research themes. The three levels of classification are meant to enable a fine-grained portfolio analysis that can inform strategic planning and funding decisions. The CADRO was developed as a dynamic portfolio analysis tool that can be used to: (i) capture the changing landscape of AD research funded by different organizations, (ii) identify opportunities for coordination of support for AD research, and (iii) identify funding gaps as well as areas of overlap within and across organizations. | late adult human, alzheimer, aging |
is used by: IADRP has parent organization: Alzheimers Association has parent organization: National Institute on Aging |
Alzheimer's disease, Aging | NIA | nlx_158474 | http://www.nia.nih.gov/research/dn/cadro-outline, http://www.nia.nih.gov/research/dn/common-alzheimers-disease-research-ontology-cadro, http://www.nia.nih.gov/sites/default/files/cadro_outline_-_january_2013.pdf | SCR_004046 | Common Alzheimer''s Disease Research Ontology, Common Alzheimer's Disease Research Ontology (CADRO) | 2026-07-25 12:05:45 | 2 | |||||
|
Reata Pharmaceuticals Resource Report Resource Website 1+ mentions |
Reata Pharmaceuticals (RRID:SCR_004040) | Reata | commercial organization | Pharmaceutical company focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) and inhibit the pro-inflammatory transcription factor NF-B (nuclear factor kappa-light-chain-enhancer of activated B cells). The antioxidative and anti-inflammatory compounds bardoxolone methyl and RTA 408 are the lead clinical development compounds in their portfolio. | pharmaceutical, drug, immuno-oncology, ophthalmology, cardiovascular, autoimmune, respiratory, antioxidant inflammation modulator, oxidative stress, medicine, dermatology, skin, eye, clinical trial, nrf2, nf-b, bardoxolone methyl, rta 408, transcription, dna, transcription factor | is related to: Kidney Health Initiative | nlx_158468 | SCR_004040 | Reata Pharmaceuticals Inc. | 2026-07-25 12:05:46 | 2 | ||||||||
|
Otsuka America Pharmaceutical Inc. Resource Report Resource Website 1+ mentions |
Otsuka America Pharmaceutical Inc. (RRID:SCR_004036) | OAPI | commercial organization | Healthcare company that oversees all pharmaceutical and medical device commercial activities of Otsuka Group (Otsuka) in North America. Products with emphasis on neuroscience, oncology, cardio-renal, and medical device markets. | pharmaceutical, medical device, neuroscience, oncology, cardio-renal, commercial | is related to: Kidney Health Initiative | nlx_158462 | http://www.otsuka-us.com/Companies/OAPI/ | SCR_004036 | Otsuka America Pharmaceutical | 2026-07-25 12:05:45 | 1 | |||||||
|
Proteon Therapeutics Resource Report Resource Website 1+ mentions |
Proteon Therapeutics (RRID:SCR_004037) | Proteon | commercial organization | A biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases. Their ongoing Phase 3 clinical trial is evaluating whether a single treatment of PRT-201 can reduce vascular access failure, one of the most serious problems experienced by patients with chronic kidney disease (CKD) undergoing hemodialysis. PRT-201 is an investigational drug that may inhibit neointimal hyperplasia, the growth of tissue inside blood vessels that can result in vessel narrowing and reduced blood flow. PRT-201 has received fast track and orphan drug designations for hemodialysis vascular access indications.In September 2019, Proteon Therapeutics merged with ArTara Therapeutics. | biopharmaceutical, pharmaceutical, hemodialysis, prt-201, drug |
is related to: Kidney Health Initiative is related to: Protara Therapeutics |
Kidney disease, Vascular disease, Chronic kidney disease, Neointimal hyperplasia, Peripheral arterial disease | nlx_158465 | SCR_004037 | Proteon Therapeutics Inc. | 2026-07-25 12:05:46 | 1 | |||||||
|
Multiple Sclerosis Society Resource Report Resource Website 10+ mentions |
Multiple Sclerosis Society (RRID:SCR_004153) | MS Society | nonprofit organization | The UK''s leading MS charity that provides information and support, funding research and fighting for change. We''re a democratic organization: one member, one vote. We fund research, give grants, campaign for change, provide information and support, invest in MS specialists and lend a listening ear to those who need it. The UK''s biggest MS charity. * 38,000 members have a say in how we''re run. * 9000 volunteers give a million hours every year. * 550 staff work in all four nations of the UK. * Over 300 branches support people with MS locally. * One aim: to beat MS. Our national offices in England, Scotland, Wales and Northern Ireland and our network of 300 branches support people affected by MS locally. | Crossref funder ID: 501100000381, ISNI: 0000 0001 0665 6519, nlx_143577, Wikidata: Q6934907, grid.453295.c | https://ror.org/043fwdk81 | SCR_004153 | 2026-07-25 12:05:47 | 18 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
